Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rifampicin Combination Therapy Versus Targeted Antimicrobial Monotherapy in the Oral Antimicrobial Treatment Phase of Staphylococcal Prosthetic Joint Infection

NCT06172010 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.

NCT NCT06172010
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06172010 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rifampicin Combination Therapy Versus Targeted Antimicrobial Monotherapy in the Oral Antimicrobial Treatment Phase of Staphylococcal Prosthetic Joint Infection
Lead sponsor
Leiden University Medical Center
Phase
Phase 4
Overall status
Recruiting
Start date
April 1, 2023
Completion date
March 31, 2028
Enrollment
316 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

infection hip, infection; knee, joint, prosthetic-joint infection